BARD1 Life Sciences Limited announced the appointment of Dr. Leearne Hinch as Chief Executive Officer, commencing November 7, 2016. Dr. Leearne Hinch is a biotechnology executive and consultant with over 20 years’ experience in the life sciences industry across general management, strategy, fundraising, business development and technology commercialisation. Leearne is currently director of commercialisation advisory Ingeneus Solutions, and has previously held CEO and executive positions in ASX-listed biotechnology, multinational and private companies including Eustralis Pharmaceuticals Ltd, Immuron Ltd, OBJ Ltd, Holista CollTech Ltd. and Virbac (Australia) Pty Ltd.